home / stock / krtx / krtx articles

KRTX Articles, Karuna Therapeutics Inc. - From 12/22/23

Stock Information
Company Name: Karuna Therapeutics Inc.
Stock Symbol: KRTX
Market: NYSE
Menu
KRTX KRTX Quote KRTX Short KRTX News KRTX Articles KRTX Message Board
Get KRTX Alerts

News, Short Squeeze, Breakout and More Instantly...
With Karuna Therapeutics $14B Deal, Bristol Myers Is Serious For Re-Establishing Its Neurology Portfolio: Analyst | Benzinga

Earlier Friday, Bristol Myers Squibb & Co (NYSE: BMY) agreed to acquire Karuna Therapeutics Inc (NASDAQ: KRTX) for $330.00 ...
Karuna Therapeutics Jumps Following Takeover By Bristol Myers, Joins Rocket Lab USA, Altair Engineering And Other Big Stocks Moving Higher On Friday | Benzinga

U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Friday. Shares of Karuna Therapeutics, Inc. (NASDAQ: KRTX) rose sh...

Health Care Company Bristol-Myers Squibb Announces Merger With Karuna Therapeutics | Benzinga

Bristol-Myers Squibb (NYSE:BMY) has announced a merger with Karuna Therapeutics (NASDAQ:KRTX) that is expected to be completed 2024-H1. Under the t...

Dow Rises 50 Points; Fed's Preferred Inflation Gauge Cools In November | Benzinga

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on Friday. Following the market opening Friday, the Do...
Bristol Myers Squibb Scoops Up Schizophrenia Player Karuna Therapeutics In Massive $14B Deal | Benzinga

On Friday, Bristol Myers Squibb & Co (NYSE: BMY) agreed to acquire Karuna Therapeutics Inc (NASDAQ: KRTX) for $330.00 per s...

Karuna Therapeutics Says Its Antipsychotic Candidate Shows Favorable Cardiovascular Safety Profile In Schizophrenia Patients | Benzinga

Karuna Therapeutics Inc (NASDAQ: KRTX) released results from its Phase 1b open-label, eight-week inpatient trial evaluating the effect of KarX...

Previous 10 Next 10